Recombinant Polypeptides Comprising Modified MHC Class II DRa1 Domains and Methods of Use
Copyright © Targeted News Service 2024
2024-04-02
ALEXANDRIA, Virginia, April 2 -- THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, Washington, District of Columbia has been assigned a patent (No. US 11945855 B2, initially filed Oct. 4, 2019) developed by three inventors Roberto Meza-Romero, Beaverton, Oregon; Arthur A. Vandenbark, Portland, Oregon; and Halina Offner, Portland, Oregon, for "Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use." . . .